Project Grant R01AG092632
- Federal Project Grant Award Summary The University of Delaware received a $2.61 million Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective September 1, 2025, through August 31, 2029. This research initiative will produce evidence-based findings on the safety and effectiveness of different hypertension treatment strategies for older adults with Alzheimer's disease and related dementias (ADRD) residing in nursing homes. The project...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $2.33 million Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) beginning September 1, 2025, and extending through August 31, 2029. This award supports biomedical research directed toward understanding neuroimmune mechanisms associated with menopause and Alzheimer's disease (AD) in the female brain. The research evaluates the therapeutic potential of...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of Colorado-Denver a $429,000 Project Grant effective January 1, 2026, through December 31, 2027, under the Aging Research program (CFDA 93.866). This award funds a two-year research investigation examining the role of estradiol in regulating protein crotonylation—a post-translational modification—in aged female cardiomyocytes. The research addresses the significant public health challenge of increased...
- Federal Grant Award Summary Iowa State University of Science and Technology received a $810,310 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 1, 2025, through August 31, 2027. This research initiative will investigate cerebral pulsatility—the discontinuous nature of blood flow in the brain—as a potential mechanism driving accelerated cerebrovascular aging and increased Alzheimer's disease and related dementias...
- Federal Project Grant Award Summary The University of Washington received a $651,175 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded February 1, 2026, with completion targeted for November 30, 2030. This award supports a longitudinal study examining the developmental pathways linking female pubertal timing to long-term cardiometabolic health outcomes and biological aging. The research utilizes participants from the National...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $126,684 Project Grant to the University of California, Los Angeles on March 18, 2026, under the Aging Research program (CFDA 93.866) for a project period extending through September 25, 2027. This award supports basic scientific research aimed at understanding the signaling mechanisms by which estrogen influences metabolic pathways during menopause. The research focuses on elucidating how circulating estrogen affects...
- Federal Project Grant Award Summary Duke University's Office of Research Administration is executing a scientific research project funded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866). The $715,801 project grant, awarded June 1, 2025, with completion scheduled for March 31, 2030, supports biomedical research investigating the mechanisms linking hypertension and aging to postoperative delirium and subsequent Alzheimer's disease and related dementias...
- Federal Project Grant Award Summary The University of California, Santa Barbara received a $4.77 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) awarded August 5, 2025, with a completion date of July 31, 2029. This award supports a multi-principal investigator research initiative investigating the effects of endocrine aging on spatial navigation ability and associated neuronal systems. The research team, composed of experts in...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of California, San Francisco (UCSF) a $3.43 million Project Grant under the Aging Research program (CFDA 93.866) effective September 15, 2025, through August 31, 2029. This research initiative investigates the biological drivers of sex differences in frontotemporal dementia (FTD), the leading cause of young-onset dementia. The project will deliver comprehensive scientific analysis of sex-specific...
- Federal Grant Award Summary The University of Delaware received a $560,380 Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded on January 15, 2026, with completion targeted for December 31, 2028. The project delivers novel biomechanical assessment capabilities for osteoarthritis research through the application of a force-sensing universal robotic testing system to characterize multi-axial joint function in mouse models. The system will quantify...
The University of Delaware received a $651,816 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) to investigate cardiovascular sympathetic nervous system dysfunction during the menopausal transition. The award, effective February 1, 2026 through January 31, 2031, will fund a comprehensive research study examining how physiological changes in follicle-stimulating hormone (FSH) and estradiol (E2) during perimenopause contribute to heightened sympathetic nervous system activity (SNA) and increased cardiovascular disease risk in women. The research will address critical gaps in understanding both central (medullary) and peripheral (vascular) mechanisms of sympathetic activation across premenopausal, early perimenopausal, late perimenopausal, and postmenopausal populations. This research directly aligns with the National Institute on Aging's mission to support biomedical research advancing understanding of age-related diseases and health conditions. The project will deliver scientific findings on the mechanistic contributions of reproductive hormone changes to cardiovascular pathophysiology during menopause, potentially informing prevention and treatment strategies for the observed increase in cardiovascular mortality among perimenopausal women. The five-year project period allows for comprehensive investigation of sympathetic function changes and their clinical implications across the menopausal transition.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $651.8k | 1/30/26 |